PROM1 and ovarian carcinoma: Thirdly, to our knowledge, for the first time, our lab has demonstrated that TF is also expressed on CSCs (positive for CSC marker CD133, CD133+) isolated from tumor cell lines, xenografts from mice, and patients’ tumor tissues of breast (including TNBC) (Figure 3c), lung, and ovarian cancer [35].